Immuneering Net Profit Margin Growth & History (IMRX)
Immuneering's net profit margin was −15,937.29% for fiscal 2022.
View full Immuneering company overviewImmuneering annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −15,937.29% | −14324.97 pp |
| 2021 | 2021-12-31 | −1,612.33% | −875.16 pp |
| 2020 | 2020-12-31 | −737.17% | — |
Immuneering quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | −2,911,112.31% | −2905424.08 pp |
| Q3 2022 | 2022-09-30 | −33,466.21% | −31696.13 pp |
| Q2 2022 | 2022-06-30 | −12,208.67% | −10998.49 pp |
| Q1 2022 | 2022-03-31 | −7,020.42% | −6187.80 pp |
| Q4 2021 | 2021-12-31 | −5,688.22% | — |
| Q3 2021 | 2021-09-30 | −1,770.08% | −1125.59 pp |
| Q2 2021 | 2021-06-30 | −1,210.18% | −460.62 pp |
| Q1 2021 | 2021-03-31 | −832.62% | — |
| Q3 2020 | 2020-09-30 | −644.49% | — |
| Q2 2020 | 2020-06-30 | −749.56% | — |
Immuneering net profit margin trends
Between the periods ended 2020-12-31 and 2022-12-31, Immuneering's net profit margin decreased from −737.17% to −15,937.29%, a change of −15200.12 percentage points. The latest reported quarter, Q4 2022, shows −2,911,112.31%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immuneering source filings ↗